الصفحة الرئيسية>>Signaling Pathways>> Proteases>> Mitochondrial Metabolism>>Asp-AMS

Asp-AMS

رقم الكتالوجGC31432

أسب-آماس، وهو مشتق أنالوج من الأسبارتيل-أدينيلات، هو مثبط لإنزيم الأسبارتيل-tRNA synthetase وكذلك مثبط تنافسي قوي للإنزيم الميتوكوندري.

Products are for research use only. Not for human use. We do not sell to patients.

Asp-AMS التركيب الكيميائي

Cas No.: 828288-98-8

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
556٫00
متوفر
5mg
506٫00
متوفر
10mg
782٫00
متوفر
25mg
1609٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Asp-AMS, an analogue of aspartyl-adenylate, is an aspartyl-tRNA synthetase inhibitor and also a strong competitive inhibitor of the mitochondrial enzyme.

Asp-AMS is a 500-fold stronger competitive inhibitor of the mitochondrial enzyme than aspartol-AMP (10 nM) and a 35-fold lower competitor of human and bovine cyt-AspRSs (300 nM). Asp-AMS is a strong inhibitor with Ki in the nanomolar (nM) range. Asp-AMS has also the highest inhibitory effect for the mitochondrial enzyme. Asp-AMS is the most active inhibitor with Ki values in the nanomolar range, with a stronger effect on bacterial AspRSs (E. coli and P. aeruginosa) than on human cytosolic AspRS[1].

[1]. Messmer M, et al. Peculiar inhibition of human mitochondrial aspartyl-tRNA synthetase by adenylate analogs. Biochimie. 2009 May;91(5):596-603.

مراجعات

Review for Asp-AMS

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Asp-AMS

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.